午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

武漢敬康恩生物醫(yī)藥科技有限公司 公司信息

公司名稱: 武漢敬康恩生物醫(yī)藥科技有限公司
電話: 13720134139 +86 -0-15871494362
電子郵件:orders@jknbiochem.com
國籍:中國
網(wǎng)址: www.jknbiochem.com
產(chǎn)品總數(shù):5825
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59

公司提供產(chǎn)品列表

TGX-221 (+/-)-7-甲基-2-(嗎啉-4-基)-9-(1-苯基氨基乙基)吡啶并[1,2-A]嘧啶-4-酮 663619-89-4
PHA-767491(HCl) PHA767491 845714-00-3
Ganetespib GANETESPIB 888216-25-9
Moclobemide (Ro 111163) 嗎氯貝胺 71320-77-9
Ulocuplumab Ulocuplumab 1375830-34-4
Brontictuzumab Brontictuzumab 1447814-75-6
Research Grade Obexelimab 奧貝利單抗 1690307-05-1
Vandortuzumab Vedotin Vandortuzumab Vedotin 1471985-92-8
Amivantamab AMIVANTAMAB (埃萬妥單抗 ) 2171511-58-1
GSK 429286A N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氫-3-吡啶甲酰胺 864082-47-3
Sparsentan 4'-[(2-丁基-4-氧代-1,3-二氮雜螺[4.4]壬-1-烯-3-基)甲基]-N-(4,5-二甲基-3-異惡唑基)-2'-(乙氧基甲基)-[1,1'-聯(lián)苯]-2-磺酰胺 254740-64-2
VR23 VR23 1624602-30-7
Anetumab Ravtansine Anetumab Ravtansine 1375258-01-7
Fletikumab 夫來庫單抗 1357158-22-5
Abituzumab Abituzumab 1105038-73-0
Lenzilumab Lenzilumab 1229575-09-0
Research Grade Tafasitamab TAFASITAMAB (ANTI-CD19) 1422527-84-1
CID 755673 2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one 521937-07-5
HMN-214 (E)-4-[2-[2-[N-乙?；?N-[(4-甲氧基苯基)磺酰]氨基]苯基]乙烯基]吡啶 1-氧化物 173529-46-9
LMK-235 N-[[6-(羥基氨基)-6-氧代己基]氧基]-3,5-二甲基-苯甲酰胺 1418033-25-6
SB 366791 3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺 472981-92-3
Tirzepatide 替爾泊肽 2023788-19-2
Tarextumab Tarextumab 1359940-55-8
Anifrolumab Anifrolumab 1326232-46-5
Emibetuzumab Emibetuzumab 1365287-97-3
Lumretuzumab Lumretuzumab 1448327-63-6
SKF38393 HCl SKF38393 HCL 62717-42-4
Eldelumab Eldelumab 946414-98-8
Ralpancizumab Ralpancizumab 1407495-04-8
Denintuzumab Mafodotin Denintuzumab Mafodotin 1399672-02-6
Lacutamab LACUTAMAB (拉可妥單抗 ) 2187368-16-5
semaglutide 司美格魯肽 99291-20-0
GW0742 GW0742 317318-84-6
A66 A66 1166227-08-2
Apoptozole BenzaMide, 4-[[2-[3,5-bis(trifluoroMethyl)phenyl]-4,5-bis(4-Methoxyphenyl)-1H-iMidazol-1-yl]Methyl]- 1054543-47-3
APS-2-79 APS-2-79 鹽酸鹽 2002381-31-7
mu-conotoxin 芋螺肽 936616-33-0
AG 490 酪氨酸磷酸化抑制劑AG 490 133550-30-8
Dapirolizumab Pegol Dapirolizumab Pegol 1416147-64-2
Coltuximab Ravtansine Coltuximab Ravtansine 1269764-99-9
Firivumab Firivumab 1443004-15-6
Lokivetmab Lokivetmab 1533403-95-0
Kartogenin 2-([1,1-聯(lián)苯]-4-基氨基甲酰)苯甲酸 4727-31-5
Oprozomib;ONX-0912 ONX0912 935888-69-0
FPS-ZM1 N-BENZYL-4-CHLORO-N-CYCLOHEXYLBENZAMIDE 945714-67-0
KC7F2 KC7F2 927822-86-4
HLCL-61 HLCL-61 鹽酸鹽 1158279-20-9
Avelumab 阿維魯單抗 1537032-82-8
Reversine REVERSINE 656820-32-5
Scriptaid SCRIPTAID 287383-59-9
Tovetumab Tovetumab 1243266-04-7
Enfortumab Vedotin 維汀-恩弗妥單抗 1346452-25-2
Pasotuxizumab Pasotuxizumab 1442657-12-6
Begelomab Begelomab 1403744-56-8
BLU-945 BLU-945 2660250-10-0
SW-033291 SW033291 459147-39-8
Daprodustat;GSK1278863 達(dá)普司他 960539-70-2
Idarucizumab Idarucizumab 1362509-93-0
Aducanumab 阿杜那單抗 1384260-65-4
Bimekizumab BIMEKIZUMAB 1418205-77-2
Guselkumab 古塞庫單抗 1350289-85-8
Tosatoxumab Tosatoxumab 1374419-41-6
Bococizumab Bococizumab 1407495-02-6
Vanucizumab Vanucizumab 1448221-05-3
Vitamin K2 (Mk7) 維生素K2 MK7 2124-57-4
GW2580 GW2580 870483-87-7
Vidofludimus;4SC-101 維多氟拉迪莫 717824-30-1
Stattic Stattic 19983-44-9
AZD9496 (E)-3-[3,5-二氟-4-[(1R,3R)-2-(2-氟-2-甲基丙基)-3-甲基-2,3,4,9-四氫-1H-吡啶并[3,4-B]吲哚-1-基]苯基]丙烯酸 1639042-08-2
ON123300 8-環(huán)戊基-7,8-二氫-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 1357470-29-1
CC122 3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4H)-基)哌啶-2,6-二酮 1015474-32-4
BMS-986165 BMS-986165 1609392-27-9
Otlertuzumab Otlertuzumab 1372645-37-8
Go 6983 3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮 133053-19-7
Sofituzumab Vedotin Sofituzumab Vedotin 1418200-58-4
Ontuxizumab Ontuxizumab 946415-62-9
Remtolumab 壬托魯單抗 1791410-27-9
Evinacumab Evinacumab 1446419-85-7
3-Piperidinecarboxamide, N-(4,6-difluoro-2-benzothiazolyl)-1-[2-(dimethylamino)ethyl]- 化合物MCUF-651 2747162-85-0
WP 1066 (2E)-3-(6-溴-2-吡啶基)-2-氰基-N-[(1S)-1-苯基乙基]-2-丙烯酰胺 857064-38-1
BAY-57-1293;Pritelivir 普瑞利韋 348086-71-5
Tazemetostat (EPZ-6438) EPZ-6438 1403254-99-8
BLU-9931 BLU 9931 1538604-68-0
Durvalumab 德瓦魯單抗 1428935-60-7
Atezolizumab 阿特珠單抗 1380723-44-3
Varlilumab 伐立魯單抗 1393344-72-3
dinutuximab dinutuximab 1363687-32-4
UCB-9260 UCB-9260 1515888-53-5
Vantictumab 萬替妥單抗 1345009-45-1
Lifastuzumab Vedotin Lifastuzumab Vedotin 1401812-88-1
Lulizumab Pegol Lulizumab Pegol 1421830-13-8
Imalumab Imalumab 1430205-07-4
PD 123319 ditrifluoroacetate PD 123319 二(三氟乙酸鹽) 136676-91-0
SB 742457 3-苯基磺?；?8-(哌嗪-1-基)喹啉 607742-69-8
SH-4-54 SH-4-54 1456632-40-8
Vobarilizumab Vobarilizumab 1628814-88-9
Codrituzumab 考曲妥珠單抗 1365267-33-9
Margetuximab 瑪格妥昔單抗 1350624-75-7
Abrilumab 阿利魯單抗 1342290-43-0
Emactuzumab Emactuzumab 1448221-67-7
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2007? ChemicalBook. All rights reserved.